{"product_id":"cardiovascular-effects-of-inhaled-ultrafine-and-nanosized-particles-9780470433539","title":"Cardiovascular Effects of Inhaled Ultrafine and","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"It is timely and detailed in its account of complex issues attending air pollution related to the cardiovascular and cardiopulmonary systems. . . This book could well be the most important occupational and environmental health book I have ever read.\" (Doody's, 16 September 2011)  \u003cp\u003e \u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eFOREWORD.  \u003cp\u003ePREFACE.\u003c\/p\u003e \u003cp\u003eTHE EDITORS.\u003c\/p\u003e \u003cp\u003eCONTRIBUTORS.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART I. ISSUE FRAMING.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 1\u003c\/b\u003e OVERVIEW (Flemming R. Cassee and Morton Lippmann).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 2\u003c\/b\u003e ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION (Krishnan Bhaskaran, Shakoor Hajat, and Liam Smeeth).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 3\u003c\/b\u003e CHRONIC EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH (Ranjini M. Krishnan, Joel Kaufman, and Gerard Hoek).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART II. EXPOSURE.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 4\u003c\/b\u003e PARTICLE CHARACTERIZATION (Thomas A.J. Kuhlbusch and Christof Asbach).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 5\u003c\/b\u003e EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES (Timo Lanki, Josef Cyrys, H.-Erich Wichmann, and Jeroen de Hartog).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 6\u003c\/b\u003e FROM EXPOSURE TO DOSE (Werner Hofmann and Bahman Asgharian).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 7\u003c\/b\u003e TRANSLOCATION OF INHALED NANOPARTICLES (Wolfgang G. Kreyling, Winfried Möller, Otmar Schmid, Manuela Semmler-Behnke, and Günter Oberdörster).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 8\u003c\/b\u003e ROLE OF CHEMICAL COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLES (Andrew J. Ghio and Yuh-Chin T. Huang).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART III. METHODOLOGY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 9\u003c\/b\u003e IN VITRO STUDIES (Per E. Schwarze and Gerrit M. Alink).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 10\u003c\/b\u003e EXPERIMENTAL STUDIES IN ANIMALS (Urmila P. Kodavanti, Lung-Chi Chen, and Daniel L. Costa).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 11\u003c\/b\u003e HUMAN EXPOSURE STUDIES (Jeremy P. Langrish, Mark W. Frampton, and Anders Blomberg).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 12\u003c\/b\u003e PANEL STUDIES (Joel Schwartz).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eA. ATHEROGENESIS.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 13\u003c\/b\u003e PARTICULATES AND OXIDATIVE STRESS (Steffen Loft, Roel P.F. Schins, and Peter Møller).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 14\u003c\/b\u003e ROLE OF INFLAMMATION IN THE ATHEROGENIC EFFECTS OF PARTICULATE MATTER (Thomas Sandström and David Newby).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 15\u003c\/b\u003e INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS (Carlijne Hassing, Maarten J.M. Cramer, and Marcel Th.B. Twickler).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 16\u003c\/b\u003e INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANS (Barbara Hoffmann and Nino Künzli).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 17\u003c\/b\u003e EFFECTS OF NANOPARTICLES ON THE PULMONARY VASCULATURE (Laurel E. Plummer, Kent E. Pinkerton, Amy K. Madl, and Dennis W. Wilson).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 18\u003c\/b\u003e PARTICULATE MATTER, HYPERTENSION, AND THE METABOLIC SYNDROME (Robert D. Brook and Sanjay Rajagopalan).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 19\u003c\/b\u003e PARTICLES AND THE VASCULAR ENDOTHELIUM (Nicholas L. Mills and Mark R. Miller).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eB. VASCULAR DYSFUNCTION.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eC. THROMBOSIS.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 20\u003c\/b\u003e PARTICLES, COAGULATION, AND THROMBOSIS (Evren Kilinç, Goran Rudež, Henri M.H. Spronk, Abderrahim Nemmar, Moniek P.M. de Maat, Hugo ten Cate and Marc F. Hoylaerts).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 21\u003c\/b\u003e PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS (Qinghua Sun and Xiaohua Xu).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eD. ARRHYTHMIA.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 22\u003c\/b\u003e PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM (Swapna Upadhyay, Alison Elder, Wayne E. Cascio, and Holger Schulz).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 23\u003c\/b\u003e AIR POLLUTION AND ARRHYTHMIA (Helen C. Routledge and Jonathan N. Townend).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART V. ENVIRONMENTAL AND PUBLIC HEALTH POLICY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 24\u003c\/b\u003e RISK ASSESSMENT (Robert L. Maynard and Jon G. Ayres).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 25\u003c\/b\u003e ENVIRONMENTAL REGULATION OF PARTICULATE MATTER (Richard Damberg, Klaas Krijgsheld, May Ajero, and Sophie Punte).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 26\u003c\/b\u003e FROM AMBIENT ULTRAFINE PARTICLES TO NANOTECHNOLOGY AND NANOTOXICOLOGY (Ken Donaldson and David B. Warheit).\u003c\/p\u003e \u003cp\u003eINDEX.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402331824471,"sku":"9780470433539","price":142.16,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470433539.jpg?v=1730480091","url":"https:\/\/bookcurl.com\/products\/cardiovascular-effects-of-inhaled-ultrafine-and-nanosized-particles-9780470433539","provider":"Book Curl","version":"1.0","type":"link"}